日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities

p53 移码突变与功能丧失和独特的新形态活动相结合

David R Tong, Wen Zhou, Chen Katz, Kausik Regunath, Divya Venkatesh, Chinyere Ihuegbu, James J Manfredi, Oleg Laptenko, Carol Prives

Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers

野生型和癌症相关的 p53 蛋白优先被 MDM2 降解为二聚体而非四聚体

Chen Katz, Ana Maria Low-Calle #, Joshua H Choe #, Oleg Laptenko, David Tong, Jazmine-Saskya N Joseph-Chowdhury, Francesca Garofalo, Yan Zhu, Assaf Friedler, Carol Prives

Lysines in the tetramerization domain of p53 selectively modulate G1 arrest

p53 四聚体结构域中的赖氨酸选择性调节 G1 停滞

Rachel Beckerman, Kathryn Yoh, Melissa Mattia-Sansobrino, Andrew Zupnick, Oleg Laptenko, Orit Karni-Schmidt, Jinwoo Ahn, In-Ja Byeon, Susan Keezer, Carol Prives

Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells

突变 p53 与 SWI/SNF 染色质重塑复合物协同调节乳腺癌细胞中的 VEGFR2

Neil T Pfister, Vitalay Fomin, Kausik Regunath, Jeffrey Y Zhou, Wen Zhou, Laxmi Silwal-Pandit, William A Freed-Pastor, Oleg Laptenko, Suat Peng Neo, Jill Bargonetti, Mainul Hoque, Bin Tian, Jayantha Gunaratne, Olav Engebraaten, James L Manley, Anne-Lise Børresen-Dale, Paul M Neilsen, Carol Prives

p53-Dependent induction of PVT1 and miR-1204

p53 依赖性诱导 PVT1 和 miR-1204

Anthony M Barsotti, Rachel Beckerman, Oleg Laptenko, Konrad Huppi, Natasha J Caplen, Carol Prives